Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Äèñêóññèîííûå ôîðóìû > Ðàçíîå

Ðàçíîå Ëþáûå ñîîáùåíèÿ íà ìåäèöèíñêèå òåìû, ïî êîòîðûì íåò îòäåëüíûõ ôîðóìîâ. Ôîðóì: ×àñòíàÿ ïðàêòèêà.

Çàêðûòàÿ òåìà
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 21.04.2002, 08:17
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìåäèöèíñêîå øàðëàòàíñòâî â Ðîññèè: ïðè÷èíû, ïîñëåäñòâèÿ, ïðèìåðû èç ïðàêòèêè

Óâàæàåìûå êîëëåãè, ãîñïîäà!
ß áû õîòåë íà÷àòü ýòó äèñêóññèþ ïîòîìó, ÷òî ìàñøòàáû ìåäèöèíñêîãî øàðëàòàíñòâà â Ðîññèè ÷óäîâèùíû. Ê áîëüøîìó ñîæàëåíèþ øàðëàòàíàìè ñòàíîâÿòñÿ íå òîëüêî òàê íàçûâàåìûå "àëüòåðíàòèâùèêè", íî è âðà÷è, ðàáîòàþùèå â âåñüìà ñîëèäíûõ ìåäó÷ðåæäåíèÿõ è ïðàêòèêóþùèå âïîëíå "òðàäèöèîííóþ" ìåäèöèíó. Ïðè÷èíû ýòîãî - ïðîôåññèîíàëüíàÿ áåçãðàìîòíîñòü è îáû÷íàÿ áåäíîñòü ìíîãèõ ìåäðàáîòíèêîâ. Êðîìå ýòîãî Ìèíçäðàâ ÐÔ è åãî ýêñïåðòû, ðåãèñòðèðóÿ íîâûå ìåòîäû "ëå÷åíèÿ", íå òðåáóþò ïðîâåäåíèÿ ñòàòèñòè÷åñêè êîððåêòíûõ äîêëèíè÷åñêèõ è êëèíè÷åñêèõ èññëåäîâàíèé, õîòÿ áû ïîõîæèõ íà åâðîïåéñêèé ñòàíäàðò ïîäòâåðæäåíèÿ ýôôåêòèâíîñòè ìåòîäîâ ëå÷åíèÿ è êîððåêòíîãî ïðîâåäåíèÿ êëèíè÷åñêèõ èñïûòàíèé Good Clinical Practice (GCP). Òàêèì îáðàçîì â ëå÷åáíûå ìåòîäû ïîïàäàåò òàêàÿ ãàëèìàòüÿ, ÷òî ïðîñòî äèâó äàåøüñÿ, êàê ñ ïîìîùüþ Ìèíçäðàâà ÐÔ ïðåäïðèèì÷èâûå øàðëàòàíû äóðÿò íàøå íàñåëåíèå, îòâëåêàÿ åãî îò ðåàëüíûõ âîçìîæíîñòåé ëå÷åíèÿ ïîðîé òÿæåëûõ çàáîëåâàíèé, à ìíîãèõ ïðîñòî ñâîäÿò â ãðîá. ß ïðîøó êîëëåã ïðèâåñòè ïðèìåðû èç Âàøåé ïðàêòèêè, êîòîðûå èëëþñòðèðóþò äåÿòåëüíîñòü ðàçíîãî ðîäà øàðëàòàíîâ. Ïðèâåñòè àíàëèç ïðè÷èí ñòîëü øèðîêîãî ðàñïðîñòðàíåíèÿ ýòîãî ÿâëåíèÿ â Ðîññèè. Ïîäåëèòüñÿ ìûñëÿìè î òîì, êàê ìû ìîæåì çàùèòèòü íàøèõ ïàöèåíòîâ îò ðàçíîãî ðîäà íåäîáðîñîâåñòíûõ ïðàêòèêîâ. Ñ óâàæåíèåì êî âñåì
  #2  
Ñòàðûé 21.04.2002, 13:44
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!

Ìîæåò ïåðåä òåì, êàê áóäåì êëåéìèòü «÷óäîâèùíûå ìàñøòàáû ìåäèöèíñêîãî øàðëàòàíñòâà â Ðîññèè» è ïðàêòèêóþùèõ ýòî «âðà÷åé, ðàáîòàþùèõ â âåñüìà ñîëèäíûõ ìåäó÷ðåæäåíèÿõ». Íåíàäîëãî îòâëå÷åìñÿ íà ñàìóþ ïåðåäîâóþ â ìåäèöèíñêèõ è â äðóãèõ ñôåðàõ áûòèÿ ñòðàíó – ÑØÀ. È îòâåòèì íà âîïðîñ, òàê è îñòàâøèéñÿ íà ôîðóìå áåç îòâåòà.

Ïî÷åìó:

We have been seeing a massive increase in the incidence of chronic diseases of all types all over the world in the last 150 years. The reason for this is undoubtedly the toxic pollution of our planet and man's inability to adapt to it. The use of ozone (which I will describe in great detail in this monograph) has been growing in all countries in the world except the U.S.
Ozone therapy can be beneficial to most chronic illnesses as well as come acute infections. Why do 12,000,000 Germans use it daily for their chronic illnesses and why do 7,000 German physicians administer it in their offices? Because it is a very effective treatment modality.
Why has the U.S. not seen its use become common? Very simply, "money!" The pharmaceutical industry and the FDA are keeping this wonderful tool out of the hands of physicians because it might bankrupt the pharmaceutical industry if it ever got into general usage. It's very simple! Ozone is the safest therapy available on the planet for treatment of illness and might even be the least expensive (if in the hands of the public themselves). How come you don't know about it? They don't want you to!
In the last several years there have been laws passed in 10 states that protect the physician from state medical board harassment and finally great therapies will be more available to the public in these states. These laws allow non-FDA approved therapies to be used between a physician & his patient as long as "duel-consent" is in place and the patient has been thoroughly informed. The states that have passed these laws are:
1. Georgia
2. Texas
3. Nevada
4. New York
5. New Mexico 6. Oklahoma
7. Alaska
8. Washington
9. Colorado
10. North Carolina
We have decided after years of deliberating to offer ozone therapy to our patients with chronic disease. You will be asked as usual to sign many consent forms because this is considered in the U.S. an experimental and investigational therapy, although Germany and many other countries teach it in their medical schools. It is safe, effective and over time can help treat and prevent a myriad of chronic degenerative disease.

È â òîæå âðåìÿ:

1987: Äîêòîð Ãàíñ Íàéïåð, ïðèìåíÿþùèé îçîí âðà÷ â Ãàííîâåðå, ÔÐÃ, ñîòðóäíè÷àþùèé ñ ÍÀÑÀ, áûâøèé ïðåçèäåíò Ãåðìàíñêîãî Îíêîëîãè÷åñêîãî îáùåñòâà, â èíòåðâüþ ñ âèäåîæóðíàëèñòîì Äæåôôîì Õàðø, ðàññêàçàë î ñâîåé ðàáîòå íàä ðàêîì ïðÿìîé êèøêè. Õîòÿ îí íå ìîã ðàñêðûòü èìåíà ñâîèõ ïàöèåíòîâ, îí ñêàçàë: "Ïðåçèäåíò Ðåéãàí - î÷åíü õîðîøèé ÷åëîâåê". È: "Âû íå ïðåäñòàâëÿåòå, ñêîëüêî ÷èíîâíèêîâ FDA, èõ ðîäñòâåííèêîâ è çíàêîìûõ ïðèåçæàþò êî ìíå â Ãàííîâåð â êà÷åñòâå ïàöèåíòîâ. Âû íå ïîâåðèòå, íî òàê æå è äèðåêòîðà Àìåðèêàíñêîé Ìåäèöèíñêîé Àññîöèàöèè, Àìåðèêàíñêîé Îíêîëîãè÷åñêîé Àññîöèàöèè, èëè äèðåêòîðà îðòîäîêñàëüíûõ îíêîëîãè÷åñêèõ èíñòèòóòîâ. Ýòî ôàêò".


P.S. 2001 year. Already the thirteen states that override the FDA and allow their doctors to use any therapy are: Alaska, Colorado, Florida, Georgia, Minnesota, Nevada, New Mexico, New York, North Carolina, Ohio, Oklahoma, Texas, Washington.
  #3  
Ñòàðûé 21.04.2002, 14:54
Ãîñòü (209.254.118.3)
Ãîñòü
 
Ñîîáùåíèé: n/a
Áûë çàäàí âîïðîñ: "Êòî âñòðå÷àë ìåäèöèíñêèõ øàðëàòàíîâ?"

Ïî÷åìó òî ïîñëåäîâàë áóðíûé ïðîòåñò Çàéöåâà.

Øàðëàòàíû åñòü è â àìåðèêå!
  #4  
Ñòàðûé 21.04.2002, 15:44
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Íà ýòîé è â öåëîì ðÿäå äðóãèõ äèñêóññèé «áóðíûé ïðîòåñò» ó ìåíÿ âûçâàëî, íå êîíñòàòàöèÿ ôàêòà íàëè÷èÿ øàðëàòàíîâ (äåéñòâèòåëüíî, ãäå èõ íåò), à ïðåäëàãàåìûå êðèòåðèè ðàçäåëåíèÿ íà òðàäèöèîííóþ è øàðëàòàíñêóþ ìåäèöèíó.
  #5  
Ñòàðûé 21.04.2002, 16:09
Ãîñòü (65.56.130.220)
Ãîñòü
 
Ñîîáùåíèé: n/a
Êòî ðàçäåëÿåò òðàäèöèîííîå è àëüòåðíàòèâíîå øàðëàòàíñòâî? Íàñêîëüêî ÿ ïîíÿë Æèâîâ ïèñàë: "Ê áîëüøîìó ñîæàëåíèþ øàðëàòàíàìè ñòàíîâÿòñÿ íå òîëüêî òàê íàçûâàåìûå "àëüòåðíàòèâùèêè", íî è âðà÷è, ðàáîòàþùèå â âåñüìà ñîëèäíûõ ìåäó÷ðåæäåíèÿõ è ïðàêòèêóþùèå âïîëíå "òðàäèöèîííóþ" ìåäèöèíó. Ïðè÷èíû ýòîãî - ïðîôåññèîíàëüíàÿ áåçãðàìîòíîñòü è îáû÷íàÿ áåäíîñòü ìíîãèõ ìåäðàáîòíèêîâ."

Âîïðîñ â äðóãîì: ïî÷åìó, êîãäà êòî-òî íà÷èíàåò ãîâîðèòü î øàðëàòàíñòâå íèêòî íå îáèæàåòñÿ êðîìå Çàéöåâà?
  #6  
Ñòàðûé 21.04.2002, 16:30
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Óâàæàåìûé Ãîñòü!
Òàê êàê ÿ óæå äàâíî äèñêóòèðóþ ñ ä-ðîì Æèâîâîì, ïîëàãàþ, ÷òî îí âñå æå ïîäðàçóìåâàë äðóãîå: ÷òî âðà÷è, ðàáîòàþùèå â âåñüìà ñîëèäíûõ ìåäó÷ðåæäåíèÿõ, âñå ÷àùå, íàðÿäó ñ òðàäèöèîííûìè ìåòîäèêàìè, íà÷èíàþò èñïîëüçîâàòü «øàðëàòàíñêèå».
Íà âîïðîñ, ïî÷åìó «íèêòî íå îáèæàåòñÿ, êðîìå Çàéöåâà», Âû íàñêîëüêî ÿ ïîíÿë, ñàìè è îòâåòèëè: â ñìûñëå - íà âîðå øàïêà ãîðèò. Íå òàê ëè?
  #7  
Ñòàðûé 21.04.2002, 16:41
Ãîñòü (65.56.130.220)
Ãîñòü
 
Ñîîáùåíèé: n/a
À êàê âû ñàìè äóìàåòå?

Âû ñàìè âñòðå÷àëè ìåäèöèíñêèõ øàðëàòàíîâ? Ïðèâåäèòå ïðèìåðû, Çàéöåâ.
  #8  
Ñòàðûé 21.04.2002, 16:47
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
×òî-òî íå ïîíÿë, Âàø ïîñëåäíèé âîïðîñ. Âû æå íà íåãî, êàæåòñÿ, óæå îòâåòèëè â ïðåäûäóùåì ñîîáùåíèè. Èëè Âû ñ÷èòàåòå, ÷òî ÿ íèêîãäà íå ñìîòðþñü â çåðêàëî?
  #9  
Ñòàðûé 21.04.2002, 17:21
Ãîñòü (65.58.43.75)
Ãîñòü
 
Ñîîáùåíèé: n/a
ß èìåþ ââèäó, ìîæåò âû çíàåòå åùå êàêîé-íèáóäü ïðèìåð øàðëàòàíñòâà â òðàäèöèîííîé èëè "àëüòåðíàòèâíîé" ìåäèöèíå?
  #10  
Ñòàðûé 21.04.2002, 18:44
Àâàòàð äëÿ yakov
yakov yakov âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ãîðîä: Áîëüøîé ãîðîä
Ñîîáùåíèé: 2,819
Ïîáëàãîäàðèëè 4 ðàç(à) çà 3 ñîîáùåíèé
yakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyakov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íà ýòîì ôîðóìå àêòèâíî "êîíñóëüòèðóåò" è "ëå÷èò" îò âñåõ áîëåçíåé íåêèé ãîñïîäèí ñ íåèçâåñòíûì íèêîìó îáðàçîâàíèåì. Íàçûâàòü íå áóäó, ò.ê. âñå çíàþò. "Ëå÷èò" îí çàðÿæåííîé âîäîé. Âîò Âàì è ïðèìåð.
Åñòü åùå Ïðóãàëîâ è ×åðíûé - äèàãíîñòèêà è ëå÷åíèå ïî ôîòîãðàôèè. Ê ñ÷àñòüþ, èõ âîâðåìÿ èçãíàëè ñ ôîðóìà.
  #11  
Ñòàðûé 21.04.2002, 18:51
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Óâàæàåìûé Ãîñòü!
À òàêîãî êîíòðàñòíîãî è âîçìóòèòåëüíîãî, êàêîé ñåé÷àñ ó Âàñ ïåðåä ãëàçàìè, íåäîñòàòî÷íî? Ìîæíî òîëüêî âîñõèùàòüñÿ Âàøèì ñàìîîáëàäàíèåì, ÷òî òàê ñïîêîéíî ïðîäîëæàåòå ñî ìíîé ðàçãîâàðèâàòü.
  #12  
Ñòàðûé 21.04.2002, 20:04
Ãîñòü (166.90.70.90)
Ãîñòü
 
Ñîîáùåíèé: n/a
Âîò âèäèòå, ïðèìåðîâ ìîæíî íàéòè ìíîæåñòâî.

ß íå äóìàþ, ÷òî äîêòîð Æèâîâ íà÷èíàÿ òåìó î ìåäèöèíñêèõ æèëèêàõ èìåë ââèäó Âàñ. ß íå ïîíèìàþ ïî÷åìó Âû âñòóïèëè â äèñêóññèþ, íà÷àëè âäðóã îáèæàòüñÿ è çàùèùàòü ñâîþ îçîíîòåðàïèþ?

Êàê ñïðàâåäëèâî óêàçàë ßêîâ, ïðèìåðîâ ìàññà è îãðàíè÷èâàòüñÿ òîëüêî Âàìè ÿâëÿåòñÿ îøèáêîé.  îäíîé òîëüêî Ìîñêâå ñîòíè ìåäèöèíñêèõ øàðëàòàíîâ, à Âû âñå òîëüêî î ñåáå. Ïîýòîìó ÿ è ñïðîñèë, íå çíàåòå ëè âû äðóãèå ïðèìåðû.
  #13  
Ñòàðûé 22.04.2002, 00:06
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Óâàæàåìûé Ãîñòü (ìîæåò Âû íàçîâåòåñü, à òî êàê-òî íåóäîáíî?)
Åñëè ñåðüåçíî, ÿ òîæå èìåë âèäó íå òîëüêî è äàæå íå ñòîëüêî îçîíîòåðàïèþ. Îíà â ìîåé «çàùèòå» ñîâåðøåíî íå íóæäàåòñÿ.
Íî ÿ ïðåäëàãàþ ÷óòü-÷óòü ïðèêîñíóòüñÿ ê èñòîðèè ìåäèöèíû. Ìîæåò ïðèñóòñòâóþùèå ïðèïîìíÿò, êàê è ñ êàêèìè ïåðèïåòèÿìè ïðîáèâàëèñü öåëûé ðÿä ïðèâû÷íûõ, òðàäèöèîííûõ â íàñòîÿùåå âðåìÿ ìåòîäèê. Êàêèìè ýïèòåòàìè îíè â ñâî¸ âðåìÿ íàãðàæäàëèñü.
Ìîãó ñäåëàòü ïî÷èí: ïðèìåð, ïðàâäà, äîâîëüíî äðåâíèé, íî êàñàåòñÿ ñòðàäàíèé îãðîìíîãî êîëè÷åñòâà áîëüíûõ íà îïåðàöèîííûõ ñòîëàõ íå îäíî äåñÿòèëåòèå. Ñ ìîìåíòà îòêðûòèÿ àíåñòåçèðóþùåãî äåéñòâèÿ Dinitrogen oxide (çàêèñè àçîòà) è ïåðâûõ ýêñïåðèìåíòàõ íà æèâîòíûõ äî åãî ïðèìåíåíèÿ â õèðóðãèè, ïðîøëî áîëåå ïîëóâåêà. Åùå çà ïÿòü ëåò äî ýòîãî, èçâåñòíûé õèðóðã Àëüôðåä Âåëüïî óòâåðæäàë: "Óñòðàíåíèå áîëè â õèðóðãèè - õèìåðà. Ñåãîäíÿ àáñóðäíî ïðîäîëæàòü ïûòàòüñÿ åãî äîñòè÷ü. "Íîæ" è "áîëü" - äâà ñëîâà â õèðóðãèè, êîòîðûå äîëæíû íàâñåãäà àññîöèèðîâàòüñÿ äðóã ñ äðóãîì â ñîçíàíèè ïàöèåíòà. Ìû áóäåì äîëæíû ïðèâûêíóòü ê ýòîé âûíóæäåííîìó ñî÷åòàíèþ". Åñëè ýêñòðàïîëèðîâàòü ýòîò ïðèìåð íà ñåãîäíÿøíèé äåíü, òî ñàì ôàêò àíåñòåçèðóþùåãî äåéñòâèÿ Dinitrogen oxide, áîëüøîãî êîëè÷åñòâà ýêñïåðèìåíòîâ íà æèâîòíûõ, ìíîãî÷èñëåííûõ ëàáîðàòîðíûõ àíàëèçîâ, âêëþ÷àÿ åñòåñòâåííî, òîêñèêîëîãèþ, ìóòàãåííîñòü è ìí. äð. áûëî áû íåäîñòàòî÷íî. Çîëîòîé (â ñìûñëå î÷åíü äîðîãîé) ñòàíäàðò - âåðà òîëüêî â äâîéíóþ ñëåïóþ îáøèðíóþ ñòàòèñòèêó. Áåç ýòîãî, ëþáûå êëèíè÷åñêèå èñïûòàíèÿ ôèêñèðóþùèå «áîëüíî, íå áîëüíî» - ñèíîíèì øàðëàòàíñêîé ìåäèöèíû. Êëèíè÷åñêèå èñïûòàíèÿ ëèòîòðèïñèè òîæå áûëè ïëàöåáî êîíòðîëèðóåìûå?

Ìîæíî îáðàòèòüñÿ ê çíà÷èòåëüíî áîëåå ïîçäíèì ïðèìåðàì êàê âñòðå÷àëèñü òå èëè èíûå ìåäèöèíñêèå íîâàöèè, íî òåïåðü âàøà î÷åðåäü….
À èñòèííûì øàðëàòàíàì, òèïà Ïðóãàëîâ, GCP íå ïîìåõà. È åñëè òàêèõ øàðëàòàíîâ äîñòàòî÷íî è â ÑØÀ, òî ýòî ëèøü ëèøíåå äîêàçàòåëüñòâî, ÷òî è òàì â îôèöèàëüíîé ìåäèöèíå íå âñ¸ òàê ðàäóæíî.
  #14  
Ñòàðûé 22.04.2002, 02:56
Ãîñòü (65.58.43.108)
Ãîñòü
 
Ñîîáùåíèé: n/a
 èñòîðèè ìåäèöèíû áûëè òûñÿ÷è ïðåäëîæåííûõ ñðåäñòâ ëå÷åíèÿ, âî ìíîãèå êòî-òî êîãäà-òî íå âåðèë. Íåêîòîðûå èç íèõ â ïîñëåäóþùåì ïîêàçàëè ñâîþ ýôôåêòèâíîñòü â ýêñïåðèìåíòå, íåêîòîðûå íåò. Ôàêò, ÷òî êòî-òî â ÷òî-òî íå âåðèë íå äîêàçûâàåò ýôôåêòèâíîñòü îçîíà. Ñàì ôàêò ïðèâîäèìîãî àðãóìåíòà ãîâîðèò ñàì çà ñåáÿ. Âîîáùå, õîðîøåé ëàêìóñîâîé áóìàæêîé íà îáíàðóæåíèå øàðëàòàíîâ ÿâëÿåòñÿ íåíàâèñòü ê íàó÷íîìó èññëåäîâàíèþ è ëþáîâü ê ïóñòîé íî íàïûùåííîé áîëòîâíå.
  #15  
Ñòàðûé 22.04.2002, 03:38
V. ZAITSEV V. ZAITSEV âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.07.2001
Ñîîáùåíèé: 3,330
V. ZAITSEV
Âîò áû è ðàñêðûëèñü, ðàññêàçàëè îá ñâîèõ íàó÷íûõ èññëåäîâàíèÿõ. Èëè Âû ðàñêàèâàþùèéñÿ Ïðóãàëîâ, ðåøèâøèé òàéíî èñïîâåäîâàòüñÿ?
Çàêðûòàÿ òåìà



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 10:31.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.